The home infusion industry is experiencing significant growth due to the increasing number of aging patients wanting to ...

Jet lag is a common travel nuisance that can turn an exciting journey into an exhausting ordeal. It occurs when there’s a mismatch between your internal body clock and the new time zone you’re in.

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

The Quadruple Aim—a framework originally rooted in improving patient experience, enhancing population health, and achieving ...

North Carolina hospitals reeling from Hurricane Helene may soon get some relief from a critical IV fluid shortage ... date on multiple types of intravenous and sterile fluids made by Baxter ...

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance ...

MaineHealth Franklin Hospital held a ribbon cutting and open house for the newly renovated Cancer Care and IV Therapy center.

Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports ...

29. The company has activated multiple strategies to keep IV supplies afloat. On October 18, Baxter laid out new details on a sweeping importation plan to help critical intravenous fluids reach U ...

Principal treatment-related toxicities that come from amivantamab administration include skin-related reactions, higher risk of venous thrombolism, and infusion-related reactions.

Celltrion USA has expanded access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous (SC) infliximab, to a significant share of the U.S. market ...

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...